Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1974 Dec 7;111(11):1218–1222.

Effects of levodopa therapy in Parkinson's disease II. Measurement of behavioural changes

Ruth Radbill, Gilbert Rosenberg, Arthur Schwartz
PMCID: PMC1955917  PMID: 4434291

Abstract

Forty-seven patients with Parkinson's disease were evaluated prior to and during levodopa treatment (at five weeks and at six months), to obtain quantitative measures of the effects of the disease and of levodopa on a variety of cognitive and psychomotor functions, by means of psychological tests and special apparatus. Analysis of the findings in relation to a comparable control group shows that before treatment patients had impaired performance of all motor tasks, but no differences in cognitive functioning were found. Most motor functions had improved after five weeks on levodopa and this improvement was maintained at the six-month follow-up, but cognitive functions remained largely unchanged. The relationship between patients' age, disability, duration of illness and drug tolerance is also discussed in relation to the functions measured.

Full text

PDF
1218

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asso D., Crown S., Russell J. A., Logue V. Psychological aspects of the stereotactic treatment of Parkinsonism. Br J Psychiatry. 1969 May;115(522):541–553. doi: 10.1192/bjp.115.522.541. [DOI] [PubMed] [Google Scholar]
  2. BURNS B. D., DEJONG J. D. A preliminary report on the measurement of Parkinson's disease. Neurology. 1960 Dec;10:1096–1102. doi: 10.1212/wnl.10.12.1096. [DOI] [PubMed] [Google Scholar]
  3. Barbeau A. Long-term side-effects of levodopa. Lancet. 1971 Feb 20;1(7695):395–395. doi: 10.1016/s0140-6736(71)92226-4. [DOI] [PubMed] [Google Scholar]
  4. Blonsky E. R. The role of L-dopa in the functional rehabilitation of patients with Parkinson's disease. IMJ Ill Med J. 1971 Feb;139(2):144–151. [PubMed] [Google Scholar]
  5. Christensen A. L., Juul-Jensen P., Malmros R., Harmsen A. Psychological evaluation of intelligence and personality in parkinsonism before and after stereotaxic surgery. Acta Neurol Scand. 1970;46(4):527–537. doi: 10.1111/j.1600-0404.1970.tb05810.x. [DOI] [PubMed] [Google Scholar]
  6. Godwin-Austen R. B., Tomlinson E. B., Frears C. C., Kok H. W. Effects of L-dopa in Parkinson's disease. Lancet. 1969 Jul 26;2(7613):165–168. doi: 10.1016/s0140-6736(69)91417-2. [DOI] [PubMed] [Google Scholar]
  7. KAPLAN H. A., MACHOVER S., RABINER A. A study of the effectiveness of drug therapy in parkinsonism. J Nerv Ment Dis. 1954 May;119(5):398–411. doi: 10.1097/00005053-195405000-00003. [DOI] [PubMed] [Google Scholar]
  8. Lee J. E., Sweet R. D., McDowell F. H. Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatment. Ann Intern Med. 1971 Nov;75(5):703–708. doi: 10.7326/0003-4819-75-5-703. [DOI] [PubMed] [Google Scholar]
  9. Loranger A. W., Goodell H., Lee J. E., McDowell F. Levodopa treatment of Parkinson's syndrome. Improved intellectual functioning. Arch Gen Psychiatry. 1972 Feb;26(2):163–168. doi: 10.1001/archpsyc.1972.01750200067014. [DOI] [PubMed] [Google Scholar]
  10. Loranger A. W., Goodell H., McDowell F. H., Lee J. E., Sweet R. D. Intellectual impairment in Parkinson's syndrome. Brain. 1972;95(2):405–412. doi: 10.1093/brain/95.2.405. [DOI] [PubMed] [Google Scholar]
  11. Loranger A. W., Goodell H., McDowell F. H., Lee J. E., Sweet R. D. Parkinsonism, L-dopa, and intelligence. Am J Psychiatry. 1973 Dec;130(12):1386–1389. doi: 10.1176/ajp.130.12.1386. [DOI] [PubMed] [Google Scholar]
  12. MAXWELL E. Validities of abbreviated WAIS scales. J Consult Psychol. 1957 Apr;21(2):121–126. doi: 10.1037/h0041857. [DOI] [PubMed] [Google Scholar]
  13. Marsh G. G., Kravitz E. A. Increase in fine motor control in Parkinson patients following levodopa. Percept Mot Skills. 1971 Aug;33(1):211–215. doi: 10.2466/pms.1971.33.1.211. [DOI] [PubMed] [Google Scholar]
  14. Marsh G. G., Markham C. M., Ansel R. Levodopa's awakening effect on patients with Parkinsonism. J Neurol Neurosurg Psychiatry. 1971 Jun;34(3):209–218. doi: 10.1136/jnnp.34.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Meier M. J., Martin W. E. Intellectual changes associated with levodopa therapy. JAMA. 1970 Jul 20;213(3):465–466. [PubMed] [Google Scholar]
  16. Nakano K. K., Tyler H. R. A double-blind study of the effects of levodopa in Parkinson's disease. Neurology. 1971 Oct;21(10):1069–1074. doi: 10.1212/wnl.21.10.1069. [DOI] [PubMed] [Google Scholar]
  17. O'Brien C. P., DiGiacomo J. N., Fahn S., Schwarz G. A. Mental effects of high-dosage levodopa. Arch Gen Psychiatry. 1971 Jan;24(1):61–64. doi: 10.1001/archpsyc.1971.01750070063008. [DOI] [PubMed] [Google Scholar]
  18. Puca F. M., Micalizzi V., Megna G. F., Barbieri N. F., Pigneri M. T. Valutazione psicologica del trattamento con amantadina della sindrome parkinsoniana e analisi comparativa con gli effetti della L-dopa. Acta Neurol (Napoli) 1971 Nov-Dec;26(6):707–730. [PubMed] [Google Scholar]
  19. RIKLAN M., DILLER L. Visual motor performance before and after chemosurgery of the basal ganglia in Parkinsonism. J Nerv Ment Dis. 1961 Apr;132:307–314. doi: 10.1097/00005053-196104000-00005. [DOI] [PubMed] [Google Scholar]
  20. Schwartz A., Rosenberg G., Spencer A., Barbeau A., Mars H., Libman I. The effects of levodopa therapy in patients with Parkinson's disease. I. Clinical response. Can Med Assoc J. 1972 Nov 18;107(10):973–976. [PMC free article] [PubMed] [Google Scholar]
  21. Stern P. H., McDowell F., Miller J. M., Robinson M. B. Levodopa therapy effects on natural history of Parkinsonism. Arch Neurol. 1972 Dec;27(6):481–485. doi: 10.1001/archneur.1972.00490180017005. [DOI] [PubMed] [Google Scholar]
  22. Stern P. H., McDowell F., Miller J. M., Robinson M. Levodopa and physical therapy in treatment of patients with Parkinson's disease. Arch Phys Med Rehabil. 1970 May;51(5):273–277. [PubMed] [Google Scholar]
  23. TALLAND G. A. MANUAL SKILL IN PARKINSON'S DISEASE. Geriatrics. 1963 Aug;18:613–620. [PubMed] [Google Scholar]
  24. Warburton J. W. Memory disturbance and the Parkinson syndrome. Br J Med Psychol. 1967 Jun;40(2):169–171. doi: 10.1111/j.2044-8341.1967.tb00566.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES